| ACTINIUM PHARMAC. DL-,001 |
| USA |
| Gesundheit |
| US00507W2061 / A2QA48 |
| 7AY1 (Frankfurt) |
| FRA:7AY1, ETR:7AY1, 7AY1:GR |
| - |
| https://www.actiniumpharm.. |
|
Actinium Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer. The company's primary aim is to harness the power of radioisotopes in conjunction with proprietary tumor-targe..
>Volltext.. |
| 26.91 Mio. EUR |
| -17.6 Mio. EUR |
| 0.08 Mio. EUR |
| -31.64 Mio. EUR |
| -29.97 Mio. EUR |
| -0.96 EUR |
| 0.99 Mio. EUR |
| 46.25 Mio. EUR |
| -21.69 Mio. EUR |
| 7.81 |
| 5.43% |
| 19.76% |
| - |
| - |
| - |
| - |
| ACTINIUM |
| 03.04.26 |
|
||||
|
||||
|